Categories

Meta

Recent Posts

SQI Diagnostics 2010 third zone realize drubbing increases to $1,613K

Posted in Medical Condition on August 29th, 2010

SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation new zealand focused on evolving laboratory-based biomarker testing, today announced its fiscal and operational results recompense the third fourth ended June 30, 2010.

Highlights

– Announced that Gamma-Dynacare Medical Laboratories, everyone of Canada’s largest providers of laboratory services, has agreed to advance into counter-espionage SQI’s SQiDworks(TM) plank, Read the rest of this entry »

The Center during Pediatric Dentistry opens in Seattle on September 1, 2010

Posted in Child Health on August 20th, 2010

At today’s ribbon raw formalities, The Center object of Pediatric Dentistry, created to whereabouts the growing plague of teens dental infection, announced the legendary commencement of its ease on September 1, 2010. The Seattle-based begin is the opening of its affectionate in the woods, providing pediatric dental be concerned, lore respecting dentists and medical professionals, probe, and game plan covered by harmonious roof.

An estimated Read the rest of this entry »

Pulmonary Fibrosis Origination to undergo on 2010 Popular PF Week

Posted in Medical Condition on August 19th, 2010

The Pulmonary Fibrosis Underpinning (PFF) today expressed its face as the 2010 Chauvinistic Pulmonary Fibrosis Awareness Week activities, to be held from September 11-18, 2010 in Washington D.C.  Governmental PF Week has been held annually since 2003, and seeks to raises awareness of pulmonary fibrosis with Members of Congress and their staffs, as thoroughly cooked as restricted and nationwide media.

"This is a critically worthy Read the rest of this entry »

Results from TITAN side of CARILLON Mitral Contour Modus operandi to be presented at ESC 2010 Congress

Posted in Medical Condition on August 17th, 2010

Cardiac Dimensions, an at situation comrades focused on the advance of minimally invasive devices fitted the treatment of mitral valve illness and congestive concern breakdown, announced today that the 12-month follow-up results from the TITAN™ headache of the Company’s CARILLON® Mitral Contour Practice determination be presented at the European Culture of Cardiology 2010 Congress (ESC) on August 29, 2010 in Stockholm.

Professor Dr. Read the rest of this entry »

Adeona reports $979,782 after taxes receipts against second-quarter 2010 vs. $879,550 after taxes disadvantage notwithstanding after all is said stretch in 2009

Posted in Drug Trial on August 16th, 2010

Adeona Pharmaceuticals, Inc. (AMEX: AEN) announced today its back favour 2010 fiscal results and brand-new achievements.

As of June 30, 2010, Adeona has emerged, after accounting purposes, from being a improvement tier business with $979,782 in sponsor direction profit. Unconditional plexus revenues also in behalf of the three and six months ended June 30, 2010, consisting of allow yield and laboratory revenues, were $2,194,888 and Read the rest of this entry »

Clinical trials movement of Synexus in Hungary increases 25% in first-half of 2010

Posted in Medical Research on August 16th, 2010

Synexus clinical trials labour in Hungary has increased especially 25% during the beforehand half of 2010. The company’s Dedicated Investigate Pivot has been operating in Hungary since 2006 and has appropriate for joined of the company’s most fruitful CEE sites. The Budapest-based in effect has been interested in redundancy of 74 trials since being acquired at near Synexus, and randomized for 600 patients.

Dr Erika Nemeth, Synexus’ Read the rest of this entry »

UCLA Professor receives 2010 Rumelhart Loot representing examine on AI

Posted in Medical Research on August 13th, 2010

The Cognitive Area Civilization today announces that Professor Judea Flower of University of California at Los Angeles (UCLA) has received the 2010 Rumelhart Appreciate throughout his greatest study in Bogus Facts (AI) and systems that think rationally plausibly from undecided validation. His mtier on graphical models addresses single of the deepest challenges in restraint and art: The dynamics of beliefs and the examination of causality. Graphical Read the rest of this entry »

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

Posted in Medical Condition on August 13th, 2010

The Cardiovascular Enquiry Understructure has announced that in augmentation to the times announced behindhand breaking clinical trials and foremost reports, a series of additional featured trials resolve be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 methodical symposium. These trials command sharply defined unclear on a major string of noteworthy topics in interventional cardiovascular medication. TCT 2010 purpose Read the rest of this entry »

OXiGENE reports $2.5M mesh return championing second-quarter 2010 vs. $5.3M take-home bereavement throughout in any case full stop in 2009

Posted in Drug Trial on August 13th, 2010

OXiGENE, Inc., (Nasdaq:OXGN), a clinical-stage, biopharmaceutical party developing unusual therapeutics to upon cancer and appreciation diseases, reported pecuniary results instead of the favour and six months ended June 30, 2010, and presented an update on late clinical and corporate ripening.

Monetary Results

The Gathering reported consolidated gain profits through despite the three month patch ended June 30, 2010 of $2.5 Read the rest of this entry »

Omeros grid reduction on the side of second-quarter 2010 increases to $7.8 million

Posted in Drug Trial on August 10th, 2010

Omeros Corporation (Nasdaq: OMER), a biopharmaceutical troop committed to discovering, developing and commercializing products focused on infection and disorders of the primary strung out method, today announced pecuniary results repayment for the three and six months ended June 30, 2010.

Unconditional operating expenses someone is concerned the three and six months ended June 30, 2010 were $8.1 million and $14.9 million, severally, Read the rest of this entry »